ArticleFrontiers in oncology2021

LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.

Yufei Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.